Antonio R. Pera, Director at ANI PHARMACEUTICALS INC (ANIP), sold 3,000 shares at $60.37 ($181K) on 2023-08-14, disclosed to the SEC on 2023-08-15.
Scheduled sale ($181k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2024-03-06 | $456K | — | Filing → |
| ANIP | BUY | 2021-12-09 | $127K | — | Filing → |